Glaxosmithkline reported $2.14B in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Amgen AMGN:US $ 1510M 51M
AstraZeneca AZN:LN 1904M 375M
Aurora Cannabis Inc ACB:CN 103.36M 6.41M
Bristol Myers Squibb BMY:US $ 2677M 206M
Canopy Growth Corp WEED:CN C$ 111.51M 159.5M
Catalent CTLT:US $ 850M 38M
Corcept Therapeutics CORT:US $ 1.32M 0.07M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 263.79M 84.03M
GlaxoSmithKline GSK:LN 2136M 1509M
Glaxosmithkline GSK:US $ 2136M 1509M
Horizon Pharma HZNP:US $ 230.22M 15.15M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Johnson & Johnson JNJ:US $ 7919M 321M
Lannett LCI:US $ 75.28M 5.52M
Merk MRK:US $ 3698M 1636M
Novartis NOVN:VX SF 3749M 6M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Perrigo Ordinary Shares PRGO:US $ 749.6M 12.9M
Pfizer PFE:US $ 8671M 1339M
Phibro Animal Health PAHC:US $ 167.99M 5.95M
Prestige Brands PBH:US $ 116.94M 1.13M
Supernus Pharmaceuticals SUPN:US $ 20.46M 2.52M
Takeda 4502:JP Y 292882M 15498M
Teva Pharmaceutical TEVA:IT 1.96B 99M
Valeant Pharmaceuticals VRX:CN $ 551M 75M
Zoetis ZTS:US $ 620M 55M